ALKS logo

Alkermes (ALKS) Company Overview

Profile

Full Name:

Alkermes plc

Sector:

Healthcare

Country:

Ireland

IPO:

July 16, 1991

Indexes:

Not included

Description:

Alkermes is a biopharmaceutical company that develops innovative medicines for mental health and addiction. They focus on creating treatments for conditions like schizophrenia, depression, and opioid dependence, aiming to improve patients' lives through effective therapies and advanced drug delivery systems.

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Feb 12, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 15, 2000

Analyst ratings

Recent major analysts updates

Feb 14, 25 Goldman Sachs
Buy
Feb 13, 25 HC Wainwright & Co.
Neutral
Feb 11, 25 Deutsche Bank
Buy
Nov 13, 24 Mizuho
Outperform
Nov 5, 24 Stifel
Buy
Oct 25, 24 Piper Sandler
Overweight
Oct 25, 24 JP Morgan
Neutral
Oct 25, 24 HC Wainwright & Co.
Neutral
Oct 25, 24 Goldman Sachs
Buy
Oct 25, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Alkermes?
  • Does Alkermes pay dividends?
  • What sector is Alkermes in?
  • What industry is Alkermes in?
  • What country is Alkermes based in?
  • When did Alkermes go public?
  • Is Alkermes in the S&P 500?
  • Is Alkermes in the NASDAQ 100?
  • Is Alkermes in the Dow Jones?
  • When was Alkermes's last earnings report?
  • When does Alkermes report earnings?
  • Should I buy Alkermes stock now?

What is the ticker symbol for Alkermes?

The ticker symbol for Alkermes is NASDAQ:ALKS

Does Alkermes pay dividends?

No, Alkermes does not pay dividends

What sector is Alkermes in?

Alkermes is in the Healthcare sector

What industry is Alkermes in?

Alkermes is in the Drug Manufacturers - Specialty & Generic industry

What country is Alkermes based in?

Alkermes is headquartered in Ireland

When did Alkermes go public?

Alkermes's initial public offering (IPO) was on July 16, 1991

Is Alkermes in the S&P 500?

No, Alkermes is not included in the S&P 500 index

Is Alkermes in the NASDAQ 100?

No, Alkermes is not included in the NASDAQ 100 index

Is Alkermes in the Dow Jones?

No, Alkermes is not included in the Dow Jones index

When was Alkermes's last earnings report?

Alkermes's most recent earnings report was on Feb 12, 2025

When does Alkermes report earnings?

The next expected earnings date for Alkermes is May 1, 2025

Should I buy Alkermes stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions